Lexaria Bioscience Corp.
LEXX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348362
No open-market purchases or sales by Lexaria Bioscience Corp. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $920.0K in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Lexaria Bioscience Corp. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −3 vs. Q4 2024
- Shares held
- 1.24M
- −201.7K (−14.0%) vs. Q4 2024
- Total value
- $2.12M
- −$907.2K (−30.0%) vs. Q4 2024
- New holders
- 2
- 8 more added
- Sold out
- 5
- 4 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LEXX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $920.0K |
| Q1 2026 | 28 | $1.17M |
| Q4 2025 | 21 | $1.05M |
| Q3 2025 | 25 | $1.63M |
| Q2 2025 | 21 | $2.00M |
| Q1 2025 | 22 | $2.12M |
| Q4 2024 | 25 | $3.03M |
| Q3 2024 | 27 | $3.25M |
| Q2 2024 | 28 | $5.72M |
| Q1 2024 | 25 | $3.23M |
| Q4 2023 | 20 | $1.49M |
| Q3 2023 | 15 | $1.77M |
| Q2 2023 | 14 | $651.4K |
| Q1 2023 | 17 | $1.85M |
| Q4 2022 | 16 | $1.71M |
| Q3 2022 | 16 | $1.68M |
| Q2 2022 | 16 | $1.67M |
| Q1 2022 | 12 | $1.41M |
| Q4 2021 | 13 | $1.85M |
| Q3 2021 | 11 | $2.83M |
| Q2 2021 | 10 | $2.93M |
| Q1 2021 | 9 | $1.78M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Lexaria Bioscience Corp.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Gables Capital Management Inc. | 13 | $22 | 0.00% | 00.0% | Unchanged |
| Sound Income Strategies, LLC | 22 | $38 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 133 | $227 | 0.00% | +7+5.6% | Added |
| Farther Finance Advisors, LLC | 166 | $272 | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 382 | $653 | 0.00% | +382 | New |
| Tower Research Capital LLC (TRC) | 1,298 | $2.22K | 0.00% | −784−37.7% | Reduced |
| Advisor Group Holdings, Inc. | 1,890 | $3.23K | 0.00% | −400−17.5% | Reduced |
| Wells Fargo & Company | 2,000 | $3.42K | 0.00% | −2,000−50.0% | Reduced |
| Oakworth Capital, Inc. | 5,000 | $8.55K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 7,283 | $12.0K | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 14,033 | $24.0K | 0.00% | +33+0.2% | Added |
| Northern Trust Corp | 18,389 | $31.4K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 21,000 | $35.9K | 0.00% | −23−0.1% | Reduced |
| BlackRock, Inc. | 27,445 | $46.9K | 0.00% | 00.0% | Unchanged |
| Byrne Asset Management LLC | 28,905 | $49.4K | 0.04% | +15,905+122.3% | Added |
| Wealth Enhancement Advisory Services, LLC | 30,959 | $52.9K | 0.00% | +2,086+7.2% | Added |
| State Street Corp | 39,301 | $67.2K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Inc | 61,250 | $104.7K | 0.00% | +610+1.0% | Added |
| Vanguard Group Inc | 127,871 | $218.7K | 0.00% | +438+0.3% | Added |
| Toronto Dominion Bank | 130,025 | $222.4K | 0.00% | +130,025 | New |
| Geode Capital Management, LLC | 172,457 | $295.0K | 0.00% | +5,778+3.5% | Added |
| Invenomic Capital Management LP | 549,947 | $940.4K | 0.05% | +139,216+33.9% | Added |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −460,000−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −20,229−100.0% | Sold out |
| Scotia Capital Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −2,620−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −116−100.0% | Sold out |